Zimbabwe introduces twice-yearly HIV prevention injection for high-risk groups

abcnews.com

Zimbabwe launched a new twice-yearly HIV prevention injection, lenacapavir, for high-risk groups. The long-acting drug offers near-total protection and aims to improve adherence compared to daily pills, particularly for vulnerable populations like sex workers. This rollout, supported by PEPFAR and the Global Fund, faces challenges including cost, infrastructure, and sustained funding for broader impact.


With a significance score of 6.5, this news ranks in the top 0.1% of today's 32773 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: